Richard D Starke
Overview
Explore the profile of Richard D Starke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
450
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mobayen G, Smith K, Ediriwickrema K, Starke R, Solomonidis E, Laffan M, et al.
J Thromb Haemost
. 2023 Apr;
21(7):1802-1812.
PMID: 37011710
Background: The von Willebrand factor (VWF) is a multimeric plasma glycoprotein essential for hemostasis, inflammation, and angiogenesis. The majority of VWF is synthesized by endothelial cells (ECs) and stored in...
2.
Ishihara J, Ishihara A, Starke R, Peghaire C, Smith K, McKinnon T, et al.
Blood
. 2019 Apr;
133(24):2559-2569.
PMID: 30975637
During wound healing, the distribution, availability, and signaling of growth factors (GFs) are orchestrated by their binding to extracellular matrix components in the wound microenvironment. Extracellular matrix proteins have been...
3.
Paschalaki K, Zampetaki A, Baker J, Birrell M, Starke R, Belvisi M, et al.
Am J Respir Crit Care Med
. 2017 Jul;
197(5):665-668.
PMID: 28753388
No abstract available.
4.
Reed D, Paschalaki K, Starke R, Mohamed N, Sharp G, Fox B, et al.
FASEB J
. 2015 Mar;
29(6):2595-602.
PMID: 25746794
There is an urgent unmet need for human tissue bioassays to predict cytokine storm responses to biologics. Current bioassays that detect cytokine storm responses in vitro rely on endothelial cells,...
5.
Randi A, Laffan M, Starke R
Mediterr J Hematol Infect Dis
. 2013 Oct;
5(1):e2013060.
PMID: 24106610
The large multimeric glycoprotein Von Willebrand factor (VWF) is best known for its role in haemostasis; however in recent years other functions of VWF have been identified, indicating that this...
6.
Paschalaki K, Starke R, Hu Y, Mercado N, Margariti A, Gorgoulis V, et al.
Stem Cells
. 2013 Jul;
31(12):2813-26.
PMID: 23897750
Cardiovascular disease (CVD) is a major cause of death in smokers, particularly in those with chronic obstructive pulmonary disease (COPD). Circulating endothelial progenitor cells (EPC) are required for endothelial homeostasis,...
7.
Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells
Starke R, Paschalaki K, Dyer C, Harrison-Lavoie K, Cutler J, McKinnon T, et al.
Blood
. 2013 Jan;
121(14):2773-84.
PMID: 23355534
Von Willebrand disease (VWD) is a heterogeneous bleeding disorder caused by decrease or dysfunction of von Willebrand factor (VWF). A wide range of mutations in the VWF gene have been...
8.
Starke R, Ferraro F, Paschalaki K, Dryden N, McKinnon T, Sutton R, et al.
Blood
. 2010 Nov;
117(3):1071-80.
PMID: 21048155
The regulation of blood vessel formation is of fundamental importance to many physiological processes, and angiogenesis is a major area for novel therapeutic approaches to diseases from ischemia to cancer....